Delivery Order SPE2DB22D3501-SPE2DB24FVC46
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of Spikevax COVID-19 vaccine syringes (0.5 mL) for individuals aged 12 years and older. The potential value of this delivery order is $4,662.90, with a completion date of February 20, 2024. The contract does not have a set-aside designation....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,254.00 firm fixed-price contract is for the delivery of Spikevax COVID-19 vaccine syringes for individuals aged 12 and up. The contract has an ultimate completion date of August 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation mentioned. This contract award is...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,662.90 award is for the supply of Spikevax COVID-19 vaccine syringes (0.5mL) for individuals 12 years of age and older. The order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- This is a $4,254 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for SPIKEVAX COVID-19 vaccine syringes for individuals 12 years of age and older, with a completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a federal contract award valued at $1,383.94, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of SPIKEVAX COVID-19 vaccine syringes, 0.5 ml, for individuals 12 years and older. The contract is a firm fixed-price delivery order awarded on May 29, 2024, with a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
- This is a $8,526.60 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the provision of SPIKEVAX COVID-19 vaccine syringes (0.5 ml) to support military treatment programs and facilities. The delivery order was not set aside and is expected to be completed by January 11, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous...
- This is a $4,662.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the procurement of SPIKEVAX COVID-19 vaccine syringes, 0.5 mL, for use by those aged 12 and up. The order does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $95,742.90, is for the provision of SPIKEVAX (COVID-19 vaccine) syringes for individuals aged 12 and above, with an ultimate completion date of November 27, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) for individuals aged 12 and above. The contract has a ceiling value of $13,971.40 and an ultimate completion date of September 18, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) for individuals aged 12 and up. The firm-fixed price delivery order, valued at $17,538.22, has an ultimate completion date of November 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVC46Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $11,657.25 contract is for the delivery of SPIKEVAX COVID-19 vaccine syringes (0.5mL) for individuals 12 years and older. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This contract is a task order issued under a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the single awardee. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 4/1/24 |